Zentalis grants 26,000 inducement stock options at $4.09 per share

Zentalis Pharmaceuticals

Zentalis Pharmaceuticals

ZNTL

0.00
  • Zentalis Pharmaceuticals granted non-qualified stock options for 26,000 shares to one newly hired employee on May 1, 2026.
  • Options were issued under Zentalis 2022 Employment Inducement Incentive Award Plan.
  • Exercise price set at $4.09 per share.
  • Awards carry a 10-year term.
  • Vesting set over four years, with 25% vesting after one year.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zentalis Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605011730PRIMZONEFULLFEED9711752) on May 01, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.